Provided by Tiger Trade Technology Pte. Ltd.

Azitra Inc

0.1761
+0.039428.82%
Post-market: 0.25400.0779+44.24%19:59 EDT
Volume:120.28M
Turnover:23.81M
Market Cap:2.85M
PE:-0.08
High:0.2350
Open:0.1390
Low:0.1321
Close:0.1367
52wk High:2.66
52wk Low:0.1000
Shares:16.19M
Float Shares:16.18M
Volume Ratio:91.07
T/O Rate:743.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2500
EPS(LYR):-15.7812
ROE:-230.65%
ROA:-110.69%
PB:0.75
PE(LYR):-0.01

Loading ...

Azitra Reports Private Placement Deal

MT Newswires Live
·
10 hours ago

Azitra Inc trading resumes

TIPRANKS
·
10 hours ago

Azitra prices private placement financing of up to USD 31.4 million

Reuters
·
10 hours ago

Press Release: Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Dow Jones
·
10 hours ago

Amex Halt News Pending Lst 0.137400

THOMSON REUTERS
·
11 hours ago

Azitra Receives Notice of Non-Compliance From Nyse American and Makes Nyse American Section 610(B) Public Announcement

THOMSON REUTERS
·
Mar 14

Azitra Receives NYSE American Non-Compliance Notice on Stockholders’ Equity Requirement

Reuters
·
Mar 14

Azitra Delays Shareholder Meeting to March 6, 2026

Reuters
·
Mar 06

Anitra Q4 EPS $(0.81) Misses $(0.33) Estimate

Benzinga
·
Feb 28

Press Release: Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Dow Jones
·
Feb 28

Azitra posts FY 2025 net loss of USD 11.0 million

Reuters
·
Feb 28

Azitra FY 2025 net loss attributable to common shareholders widens 22% to USD 11.0 million

Reuters
·
Feb 28

Azitra Adds MD Anderson Cancer Center as ATR-04 Trial Site

Reuters
·
Feb 24

Azitra, Inc. Announces Addition of Md Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of Atr-04 Targeting Egfri-Associated Skin Rash

THOMSON REUTERS
·
Feb 24

Azitra to Present at BIO Investment & Growth Summit in Miami Beach

Reuters
·
Feb 19

Azitra Inc. to Hold Reconvened Special Meeting on March 6, 2026, to Vote on Proxy Proposals After Previous Lack of Quorum

Reuters
·
Feb 07

Azitra Inc. to Present Clinical Strategy at Biotech Showcase in San Francisco

Reuters
·
Jan 07

Azitra Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Dec 24, 2025

BRIEF-Azitra Receives Notice Of Acceptance Of The Listing Standards Compliance Plan From NYSE American

Reuters
·
Dec 18, 2025

Azitra Faces NYSE American Listing Compliance Deadline

Reuters
·
Dec 18, 2025